MedTrace Logo

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

NCT06148298 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2024-12-06

No results posted yet for this study

Summary

The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples.

This is a Non-Human Subject Research study. All participants are de-identified.

Conditions

  • Cancer of Pancreas

Interventions

OTHER

Non-Human Subject Research study.

This is a Non-Human Subject Research study. There is no intervention. All participants are de-identified.

Sponsors & Collaborators

  • University of Central Florida

    lead OTHER

Principal Investigators

  • Kersten Schroeder, PhD · University of Central Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-24
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06148298 on ClinicalTrials.gov